Anti-infective antibodies-Reviving an old paradigm

Vaccine

Volumn 27, Issue SUPPL.6, 2009, Pages

  Lachmann, Peter ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

Antibody therapy; Flu; Infantile diarrhoea

Indexed keywords

BACTERIUM ANTIBODY; INFLUENZA VACCINE; OVALBUMIN; RHESUS D ANTIBODY;

ARTICLE; CHICKEN; DIARRHEA; FOOD; HUMAN; INFLUENZA; INFLUENZA VIRUS A H1N1; INFLUENZA VIRUS A H5N1; NEWBORN HEMOLYTIC DISEASE; NONHUMAN; PASSIVE IMMUNIZATION; PRIORITY JOURNAL; PROPHYLAXIS; TRANSGENIC ANIMAL; VIRUS IMMUNITY; VIRUS INFECTION;

ANIMALS; ANIMALS, GENETICALLY MODIFIED; ANTIBODIES, MONOCLONAL; CHICKENS; DIARRHEA; DISEASE OUTBREAKS; EGGS; HUMANS; IMMUNIZATION, PASSIVE; INFLUENZA, HUMAN;

EID: 72049093734     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2009.09.137     Document Type: Article

References (12)

1. Parrish H.J. Bacterial and viral diseases (1948), Edinburgh, Livingstone
2. Simmons C.P., Bernasconi N.L., Suguitan A.L., Mills K., Ward J.M., Chau N.V., et al. Prophylactic and therapeutic efficacy of human monoclonal antibodies against H5N1 influenza. PLoS Med 4 5 (2007) e178
3. Renegar K.P., Small Jr. P.A., Boykins L.G., and Wright P.F. Role of IgA versus IgG in the control of influenza viral infection in the murine respiratory tract. J Immunol 173 (2004) 1978-1986
4. Lu J., Guo Z., Pan X., Wang G., Zhang D., Li Y., et al. Passive immunotherapy for influenza A H5N1 virus infection with equine hyperimmune globulin F(ab')2 in mice. Respir Res 7 1 (2006) 43-49
5. Sui J., Hwang W.C., Perez S., Wei G., Aird D., Chen L.-M., et al. Structural and functional bases for broad-spectrum neutralization of avian and human influenza A viruses. Nat Struct Mol Biol 16 (2009) [Epub 2009 Feb 22]
6. Davis D., Chaudhri B., Stephens D.M., Carne C.A., Willers C., and Lachmann P.J. The immunodominance of epitopes within the transmembrane protein (gp41) of human immunodeficiency virus type 1 may be determined by the host's previous exposure to similar epitopes on unrelated antigens. J Gen Virol 71 (1990) 1975-1983
7. Taussig M.J., and Lachmann P.J. Studies on antigenic competition. II. Abolition of antigenic competition by antibody against or tolerance to the dominant antigen: a model for antigenic competition. Immunology 22 (1972) 185-197
8. Lillico S.G., Sherman A., McGrew M.J., Robertson C.D., Smith J., Haslam C., et al. Oviduct-specific expression of two therapeutic proteins in transgenic hens. PNAS 104 6 (2007) 1771-1776
9. Harmsen M.M., and De Haard H.J. Properties, production, and applications of camelid single-domain antibody fragments. Appl Microbiol Biotechnol 77 1 (2007) 13-22
10. van der Vaart J.M., Pant N., Wolvers D., Bezemer S., Hermans P.W., Bellamy K., Sarker S.A., van der Logt C.P., Svensson L., Verrips C.T., Hammarstrom L., and van Klinken B.J. Reduction in morbidity of rotavirus induced diarrhoea in mice by yeast produced monovalent llama-derived antibody fragments. Vaccine 24 19 (2006) 4130-4137
11. Nilsson E., Amini A., Wretlind B., and Larsson A. Pseudomonas aeruginosa infections are prevented in cystic fibrosis patients by avian antibodies binding Pseudomonas aeruginosa flagellin. J Chromatogr B: Anal Technol Biomed Life Sci 856 1-2 (2007) 75-80
12. Ganguli I. Immunity for breakfast?. The Scientist 22 March (2008)